Skip to main content
. 2025 Jan 30;14:1473437. doi: 10.3389/fonc.2024.1473437

Table 1.

The demographic and clinicopathological data of the total patients.

Characteristics IIb/% IIIa/% Total/%
Cases 325(37.1) 552(62.9) 877
Median Age (range) 61(27-82) 60(24-84) 60(24-84)
Females:Males 161:164 301:251 462:415
Number of Lymph Node Metastasis Sites
1 248(76.3) 158(28.6) 406(46.3)
2 67(20.6) 170(30.8) 237(27.0)
3 9(2.8) 102(18.5) 111(12.7)
4 1(0.3) 67(12.1) 68(7.8)
5 0 33(6.0) 33(3.8)
6 0 11(2.0) 11(1.3)
7 or more 0 11(2.0) 11(1.3)
Air dissemination 52(16.0) 193(35.0) 245(27.9)
Vascular invasion 36(11.1) 167(30.2) 203(23.1)
Surgical Approach
Open 21(6.5) 41(7.4) 62(7.1)
VATS 304(93.5) 511(92.6) 815(92.9)
Surgical Method
Lobectomy 306(94.2) 526(95.3) 832(94.9)
Sleeve Lobectomy 6(1.8) 5(0.9) 11(1.3)
Bilobectomy 12(3.7) 19(3.4) 31(3.5)
Pneumonectomy 1(0.3) 2(0.3) 3(0.3)
Hypertension 105(32.3) 210(38.0) 316(36.0)
Diabetes 76(23.4) 148(26.8) 224(25.5)
Coronary Disease 64(19.7) 125(22.6) 189(21.6)
Smoking History 67(20.6) 141(25.5) 208(23.7)

The bold values represent the percentage distribution of each characteristic within the respective clinical stage (IIb or IIIa). The total percentage of cases across both stages is also provided.